These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36696843)

  • 1. Self-report and urine drug screen concordance among women with co-occurring PTSD and substance use disorders participating in a clinical trial: Impact of drug type and participant characteristics.
    Ruglass LM; Shevorykin A; Zhao Y; Killeen TK; Bauer AG; Morgan-López AA; Back SE; Fitzpatrick S; López-Castro T; Norman SB; Saavedra LM; Hien DA
    Drug Alcohol Depend; 2023 Mar; 244():109769. PubMed ID: 36696843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High on drugs: Multi-institutional pilot study examining the effects of substance use on acute pain management.
    Salottolo K; Peck L; Carrick M; Tanner A; Madayag R; McGuire E; Bar-Or D
    Injury; 2019 May; 50(5):1058-1063. PubMed ID: 30642622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of women concordant and discordant for urine drug screens for cannabis exposure and self-reported cannabis use during pregnancy.
    Bogdan R; Leverett SD; Constantino-Petit AM; Lashley-Simms N; Liss DB; Johnson EC; Lenze SN; Lean RE; Smyser TA; Carter EB; Smyser CD; Rogers CE; Agrawal A
    Neurotoxicol Teratol; 2024; 103():107351. PubMed ID: 38604316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interpersonal Violence, PTSD, and Substance Use Types among Women Receiving Substance Use Treatment.
    Goodrum NM; Bernard DL; Moreland AD
    J Dual Diagn; 2022; 18(3):123-134. PubMed ID: 35802744
    [No Abstract]   [Full Text] [Related]  

  • 5. Gender-specific predictors of methadone treatment outcomes among African Americans at an urban clinic.
    Lister JJ; Brown S; Greenwald MK; Ledgerwood DM
    Subst Abus; 2019; 40(2):185-193. PubMed ID: 30888262
    [No Abstract]   [Full Text] [Related]  

  • 6. Baseline risk factors for drug use among African-American patients during first-month induction/stabilization on methadone.
    Lister JJ; Greenwald MK; Ledgerwood DM
    J Subst Abuse Treat; 2017 Jul; 78():15-21. PubMed ID: 28554598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concordance between self-report and urine drug screen data in adolescent opioid dependent clinical trial participants.
    Wilcox CE; Bogenschutz MP; Nakazawa M; Woody G
    Addict Behav; 2013 Oct; 38(10):2568-74. PubMed ID: 23811060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine drug screen findings among ambulatory oncology patients in a supportive care clinic.
    Rauenzahn S; Sima A; Cassel B; Noreika D; Gomez TH; Ryan L; Wolf CE; Legakis L; Del Fabbro E
    Support Care Cancer; 2017 Jun; 25(6):1859-1864. PubMed ID: 28120116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concordance between Self-Reported Drug Use and Urinalysis in a Sample of Black American Women.
    McLouth CJ; Oser CB; Stevens-Watkins D
    Subst Use Misuse; 2022; 57(4):495-503. PubMed ID: 35067171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rates and types of urine drug screen false negative results compared with confirmatory toxicology testing in major trauma patients.
    Weiss ST; Veach LJ; McGill W; Brent J
    Clin Toxicol (Phila); 2022 Oct; 60(10):1122-1129. PubMed ID: 36069771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of co-occurring substance use in individuals with opioid use disorder.
    Mahoney JJ; Winstanley EL; Lander LR; Berry JH; Marshalek PJ; Haut MW; Marton JL; Kimble WD; Armistead M; Wen S; Cai Y; Hodder SL
    Addict Behav; 2021 Mar; 114():106752. PubMed ID: 33348147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Power of automated algorithms for combining time-line follow-back and urine drug screening test results in stimulant-abuse clinical trials.
    Oden NL; VanVeldhuisen PC; Wakim PG; Trivedi MH; Somoza E; Lewis D
    Am J Drug Alcohol Abuse; 2011 Sep; 37(5):350-7. PubMed ID: 21854277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Concordance of Electronic Health Record Diagnoses and Substance use Self-Reports Among Reproductive Aged Women Enrolled in a Community-Based Addiction Reduction Program.
    Campbell AG; Naz S; Gharbi S; Chambers J; Denne S; Litzelman DK; Wiehe SE
    Inquiry; 2024; 61():469580241237051. PubMed ID: 38528783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Considering the harms of our habits: The reflexive urine drug screen in opioid use disorder treatment.
    Khatri UG; Aronowitz SV
    J Subst Abuse Treat; 2021 Apr; 123():108258. PubMed ID: 33358617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hair analysis and its concordance with self-report for drug users presenting in emergency department.
    Sharma G; Oden N; VanVeldhuisen PC; Bogenschutz MP
    Drug Alcohol Depend; 2016 Oct; 167():149-55. PubMed ID: 27522871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should Urine Drug Screen be Done Universally or Selectively in Palliative Care Patients on Opioids?
    Arthur J; Childers J; Del Fabbro E
    J Pain Symptom Manage; 2023 Dec; 66(6):e687-e692. PubMed ID: 37429531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of non-concordant self-report of substance use in clinical trials research.
    Clark CB; Zyambo CM; Li Y; Cropsey KL
    Addict Behav; 2016 Jul; 58():74-9. PubMed ID: 26921721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal substance use in the rural and Appalachian state: Project WATCH study 2020-2022.
    Umer A; Garrow J; Nesbitt M; Lilly C; Lefeber C; Breyel J; John C
    J Rural Health; 2023 Sep; 39(4):804-815. PubMed ID: 36823403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Empirically contrasting urine drug screening-based opioid use disorder treatment outcome definitions.
    Brandt L; Odom GJ; Hu MC; Castro C; Balise RR;
    Addiction; 2024 Jul; 119(7):1289-1300. PubMed ID: 38616571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychiatric Comorbidity and Substance Use Outcomes in an Office-Based Buprenorphine Program Six Months Following Hurricane Sandy.
    Tofighi B; Grossman E; Goldfeld KS; Williams AR; Rotrosen J; Lee JD
    Subst Use Misuse; 2015; 50(12):1571-8. PubMed ID: 26623697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.